Mesenchymal stem/stromal cell-based therapy for the treatment of rheumatoid arthritis: An update on preclinical studies.

Lopez-Santalla M, Bueren JA, Garin MI

Open source

DOI
10.1016/j.ebiom.2021.103427
Published
2021 Jul
Container
EBioMedicine
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ebiom.2021.103427,
  title = {Mesenchymal stem/stromal cell-based therapy for the treatment of rheumatoid arthritis: An update on preclinical studies.},
  author = {Lopez-Santalla M and Bueren JA and Garin MI},
  year = {2021},
  journal = {EBioMedicine},
  doi = {10.1016/j.ebiom.2021.103427},
  url = {https://doi.org/10.1016/j.ebiom.2021.103427}
}

RIS

TY  - JOUR
TI  - Mesenchymal stem/stromal cell-based therapy for the treatment of rheumatoid arthritis: An update on preclinical studies.
AU  - Lopez-Santalla M
AU  - Bueren JA
AU  - Garin MI
PY  - 2021
JO  - EBioMedicine
DO  - 10.1016/j.ebiom.2021.103427
UR  - https://doi.org/10.1016/j.ebiom.2021.103427
ER  - 

APA

M, L., JA, B., & MI, G. (2021). Mesenchymal stem/stromal cell-based therapy for the treatment of rheumatoid arthritis: An update on preclinical studies.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2021.103427

Source records